1
|
Fansher D, Besna JN, Fendri A, Pelletier JN. Choose Your Own Adventure: A Comprehensive Database of Reactions Catalyzed by Cytochrome P450 BM3 Variants. ACS Catal 2024; 14:5560-5592. [PMID: 38660610 PMCID: PMC11036407 DOI: 10.1021/acscatal.4c00086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2024] [Revised: 03/11/2024] [Accepted: 03/12/2024] [Indexed: 04/26/2024]
Abstract
Cytochrome P450 BM3 monooxygenase is the topic of extensive research as many researchers have evolved this enzyme to generate a variety of products. However, the abundance of information on increasingly diversified variants of P450 BM3 that catalyze a broad array of chemistry is not in a format that enables easy extraction and interpretation. We present a database that categorizes variants by their catalyzed reactions and includes details about substrates to provide reaction context. This database of >1500 P450 BM3 variants is downloadable and machine-readable and includes instructions to maximize ease of gathering information. The database allows rapid identification of commonly reported substitutions, aiding researchers who are unfamiliar with the enzyme in identifying starting points for enzyme engineering. For those actively engaged in engineering P450 BM3, the database, along with this review, provides a powerful and user-friendly platform to understand, predict, and identify the attributes of P450 BM3 variants, encouraging the further engineering of this enzyme.
Collapse
Affiliation(s)
- Douglas
J. Fansher
- Chemistry
Department, Université de Montréal, Montreal, QC, Canada H2V 0B3
- PROTEO,
The Québec Network for Research on Protein Function, Engineering,
and Applications, 201
Av. du Président-Kennedy, Montréal, QC, Canada H2X 3Y7
- CGCC,
Center in Green Chemistry and Catalysis, Montreal, QC, Canada H2V 0B3
| | - Jonathan N. Besna
- PROTEO,
The Québec Network for Research on Protein Function, Engineering,
and Applications, 201
Av. du Président-Kennedy, Montréal, QC, Canada H2X 3Y7
- CGCC,
Center in Green Chemistry and Catalysis, Montreal, QC, Canada H2V 0B3
- Department
of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, QC, Canada H3T 1J4
| | - Ali Fendri
- Chemistry
Department, Université de Montréal, Montreal, QC, Canada H2V 0B3
- PROTEO,
The Québec Network for Research on Protein Function, Engineering,
and Applications, 201
Av. du Président-Kennedy, Montréal, QC, Canada H2X 3Y7
- CGCC,
Center in Green Chemistry and Catalysis, Montreal, QC, Canada H2V 0B3
| | - Joelle N. Pelletier
- Chemistry
Department, Université de Montréal, Montreal, QC, Canada H2V 0B3
- PROTEO,
The Québec Network for Research on Protein Function, Engineering,
and Applications, 201
Av. du Président-Kennedy, Montréal, QC, Canada H2X 3Y7
- CGCC,
Center in Green Chemistry and Catalysis, Montreal, QC, Canada H2V 0B3
- Department
of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, QC, Canada H3T 1J4
| |
Collapse
|
2
|
Yang H, Yu H, Stolarzewicz IA, Tang W. Enantioselective Transformations in the Synthesis of Therapeutic Agents. Chem Rev 2023; 123:9397-9446. [PMID: 37417731 DOI: 10.1021/acs.chemrev.3c00010] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/08/2023]
Abstract
The proportion of approved chiral drugs and drug candidates under medical studies has surged dramatically over the past two decades. As a consequence, the efficient synthesis of enantiopure pharmaceuticals or their synthetic intermediates poses a profound challenge to medicinal and process chemists. The significant advancement in asymmetric catalysis has provided an effective and reliable solution to this challenge. The successful application of transition metal catalysis, organocatalysis, and biocatalysis to the medicinal and pharmaceutical industries has promoted drug discovery by efficient and precise preparation of enantio-enriched therapeutic agents, and facilitated the industrial production of active pharmaceutical ingredient in an economic and environmentally friendly fashion. The present review summarizes the most recent applications (2008-2022) of asymmetric catalysis in the pharmaceutical industry ranging from process scales to pilot and industrial levels. It also showcases the latest achievements and trends in the asymmetric synthesis of therapeutic agents with state of the art technologies of asymmetric catalysis.
Collapse
Affiliation(s)
- He Yang
- State Key Laboratory of Bio-Organic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Shanghai 200032, China
| | - Hanxiao Yu
- State Key Laboratory of Bio-Organic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Shanghai 200032, China
| | - Izabela A Stolarzewicz
- State Key Laboratory of Bio-Organic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Shanghai 200032, China
| | - Wenjun Tang
- State Key Laboratory of Bio-Organic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Shanghai 200032, China
- School of Chemistry and Material Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China
| |
Collapse
|
3
|
Pogrányi B, Mielke T, Díaz-Rodríguez A, Cartwright J, Unsworth WP, Grogan G. Preparative-Scale Biocatalytic Oxygenation of N-Heterocycles with a Lyophilized Peroxygenase Catalyst. Angew Chem Int Ed Engl 2023; 62:e202214759. [PMID: 36453718 PMCID: PMC10107140 DOI: 10.1002/anie.202214759] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2022] [Revised: 11/17/2022] [Accepted: 11/30/2022] [Indexed: 12/02/2022]
Abstract
A lyophilized preparation of an unspecific peroxygenase variant from Agrocybe aegerita (rAaeUPO-PaDa-I-H) is a highly effective catalyst for the oxygenation of a diverse range of N-heterocyclic compounds. Scalable biocatalytic oxygenations (27 preparative examples, ca. 100 mg scale) have been developed across a wide range of substrates, including alkyl pyridines, bicyclic N-heterocycles and indoles. H2 O2 is the only stoichiometric oxidant needed, without auxiliary electron transport proteins, which is key to the practicality of the method. Reaction outcomes can be altered depending on whether hydrogen peroxide was delivered by syringe pump or through in situ generation using an alcohol oxidase from Pichia pastoris (PpAOX) and methanol as a co-substrate. Good synthetic yields (up to 84 %), regioselectivity and enantioselectivity (up to 99 % ee) were observed in some cases, highlighting the promise of UPOs as practical, versatile and scalable oxygenation biocatalysts.
Collapse
Affiliation(s)
- Balázs Pogrányi
- Department of Chemistry, University of York, Heslington York, YO10 5DD, UK
| | - Tamara Mielke
- Department of Chemistry, University of York, Heslington York, YO10 5DD, UK
| | - Alba Díaz-Rodríguez
- GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK
| | - Jared Cartwright
- Department of Biology, University of York, Heslington York, YO10 5DD, UK
| | - William P Unsworth
- Department of Chemistry, University of York, Heslington York, YO10 5DD, UK
| | - Gideon Grogan
- Department of Chemistry, University of York, Heslington York, YO10 5DD, UK
| |
Collapse
|
4
|
Zhu R, Liu Y, Yang Y, Min Q, Li H, Chen L. Cytochrome P450 Monooxygenases Catalyse Steroid Nucleus Hydroxylation with Regio‐ and Stereo‐selectivity. Adv Synth Catal 2022. [DOI: 10.1002/adsc.202200210] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
5
|
Charlton SN, Hayes MA. Oxygenating Biocatalysts for Hydroxyl Functionalisation in Drug Discovery and Development. ChemMedChem 2022; 17:e202200115. [PMID: 35385205 PMCID: PMC9323455 DOI: 10.1002/cmdc.202200115] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2022] [Revised: 04/05/2022] [Indexed: 11/12/2022]
Abstract
C-H oxyfunctionalisation remains a distinct challenge for synthetic organic chemists. Oxygenases and peroxygenases (grouped here as "oxygenating biocatalysts") catalyse the oxidation of a substrate with molecular oxygen or hydrogen peroxide as oxidant. The application of oxygenating biocatalysts in organic synthesis has dramatically increased over the last decade, producing complex compounds with potential uses in the pharmaceutical industry. This review will focus on hydroxyl functionalisation using oxygenating biocatalysts as a tool for drug discovery and development. Established oxygenating biocatalysts, such as cytochrome P450s and flavin-dependent monooxygenases, have widely been adopted for this purpose, but can suffer from low activity, instability or limited substrate scope. Therefore, emerging oxygenating biocatalysts which offer an alternative will also be covered, as well as considering the ways in which these hydroxylation biotransformations can be applied in drug discovery and development, such as late-stage functionalisation (LSF) and in biocatalytic cascades.
Collapse
Affiliation(s)
- Sacha N. Charlton
- School of ChemistryUniversity of Bristol, Cantock's CloseBristolBS8 1TSUK
| | - Martin A. Hayes
- Compound Synthesis and ManagementDiscovery SciencesBiopharmaceuticals R&DAstraZenecaGothenburgSweden
| |
Collapse
|
6
|
Sankaranarayanan K, Heid E, Coley CW, Verma D, Green WH, Jensen KF. Similarity based enzymatic retrosynthesis. Chem Sci 2022; 13:6039-6053. [PMID: 35685792 PMCID: PMC9132021 DOI: 10.1039/d2sc01588a] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2022] [Accepted: 04/26/2022] [Indexed: 11/29/2022] Open
Abstract
Enzymes synthesize complex natural products effortlessly by catalyzing chemo-, regio-, and enantio-selective transformations. Further, biocatalytic processes are increasingly replacing conventional organic synthesis steps because they use mild solvents, avoid the use of metals, and reduce overall non-biodegradable waste. Here, we present a single-step retrosynthesis search algorithm to facilitate enzymatic synthesis of natural product analogs. First, we develop a tool, RDEnzyme, capable of extracting and applying stereochemically consistent enzymatic reaction templates, i.e., subgraph patterns that describe the changes in connectivity between a product molecule and its corresponding reactant(s). Using RDEnzyme, we demonstrate that molecular similarity is an effective metric to propose retrosynthetic disconnections based on analogy to precedent enzymatic reactions in UniProt/RHEA. Using ∼5500 reactions from RHEA as a knowledge base, the recorded reactants to the product are among the top 10 proposed suggestions in 71% of ∼700 test reactions. Second, we trained a statistical model capable of discriminating between reaction pairs belonging to homologous enzymes and evolutionarily distant enzymes using ∼30 000 reaction pairs from SwissProt as a knowledge base. This model is capable of understanding patterns in enzyme promiscuity to evaluate the likelihood of experimental evolution success. By recursively applying the similarity-based single-step retrosynthesis and evolution prediction workflow, we successfully plan the enzymatic synthesis routes for both active pharmaceutical ingredients (e.g. Islatravir, Molnupiravir) and commodity chemicals (e.g. 1,4-butanediol, branched-chain higher alcohols/biofuels), in a retrospective fashion. Through the development and demonstration of the single-step enzymatic retrosynthesis strategy using natural transformations, our approach provides a first step towards solving the challenging problem of incorporating both enzyme- and organic-chemistry based transformations into a computer aided synthesis planning workflow. Using a large database of enzymatic transformations, similarity based enzymatic retrosynthesis search algorithm takes a holistic approach to enzymatic synthesis planning to yield a diverse set of single-step suggestions.![]()
Collapse
Affiliation(s)
- Karthik Sankaranarayanan
- Department of Chemical Engineering, Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge Massachusetts 02139 USA
| | - Esther Heid
- Department of Chemical Engineering, Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge Massachusetts 02139 USA .,Institute of Materials Chemistry, TU Wien 1060 Vienna Austria
| | - Connor W Coley
- Department of Chemical Engineering, Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge Massachusetts 02139 USA
| | - Deeptak Verma
- Computational and Structural Chemistry, Discovery Chemistry, Merck & Co., Inc. Kenilworth NJ 07033 USA
| | - William H Green
- Department of Chemical Engineering, Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge Massachusetts 02139 USA
| | - Klavs F Jensen
- Department of Chemical Engineering, Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge Massachusetts 02139 USA
| |
Collapse
|
7
|
Yan Q, Zhang X, Chen Y, Guo B, Zhou P, Chen B, Huang Q, Wang JB. From Semirational to Rational Design: Developing a Substrate-Coupled System of Glucose Dehydrogenase for Asymmetric Synthesis. ACS Catal 2022. [DOI: 10.1021/acscatal.2c00705] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Qipeng Yan
- Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education) and Key Laboratory of Phytochemistry R&D of Hunan Province, College of Chemistry and Chemical Engineering, Hunan Normal University, 410081 Changsha, P. R. China
| | - Xinhua Zhang
- Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education) and Key Laboratory of Phytochemistry R&D of Hunan Province, College of Chemistry and Chemical Engineering, Hunan Normal University, 410081 Changsha, P. R. China
| | - Yingzhuang Chen
- Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education) and Key Laboratory of Phytochemistry R&D of Hunan Province, College of Chemistry and Chemical Engineering, Hunan Normal University, 410081 Changsha, P. R. China
| | - Bin Guo
- Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education) and Key Laboratory of Phytochemistry R&D of Hunan Province, College of Chemistry and Chemical Engineering, Hunan Normal University, 410081 Changsha, P. R. China
| | - Pei Zhou
- Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education) and Key Laboratory of Phytochemistry R&D of Hunan Province, College of Chemistry and Chemical Engineering, Hunan Normal University, 410081 Changsha, P. R. China
| | - Bo Chen
- Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education) and Key Laboratory of Phytochemistry R&D of Hunan Province, College of Chemistry and Chemical Engineering, Hunan Normal University, 410081 Changsha, P. R. China
| | - Qun Huang
- Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education) and Key Laboratory of Phytochemistry R&D of Hunan Province, College of Chemistry and Chemical Engineering, Hunan Normal University, 410081 Changsha, P. R. China
| | - Jian-bo Wang
- Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education) and Key Laboratory of Phytochemistry R&D of Hunan Province, College of Chemistry and Chemical Engineering, Hunan Normal University, 410081 Changsha, P. R. China
| |
Collapse
|
8
|
Simić S, Zukić E, Schmermund L, Faber K, Winkler CK, Kroutil W. Shortening Synthetic Routes to Small Molecule Active Pharmaceutical Ingredients Employing Biocatalytic Methods. Chem Rev 2021; 122:1052-1126. [PMID: 34846124 DOI: 10.1021/acs.chemrev.1c00574] [Citation(s) in RCA: 69] [Impact Index Per Article: 23.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Biocatalysis, using enzymes for organic synthesis, has emerged as powerful tool for the synthesis of active pharmaceutical ingredients (APIs). The first industrial biocatalytic processes launched in the first half of the last century exploited whole-cell microorganisms where the specific enzyme at work was not known. In the meantime, novel molecular biology methods, such as efficient gene sequencing and synthesis, triggered breakthroughs in directed evolution for the rapid development of process-stable enzymes with broad substrate scope and good selectivities tailored for specific substrates. To date, enzymes are employed to enable shorter, more efficient, and more sustainable alternative routes toward (established) small molecule APIs, and are additionally used to perform standard reactions in API synthesis more efficiently. Herein, large-scale synthetic routes containing biocatalytic key steps toward >130 APIs of approved drugs and drug candidates are compared with the corresponding chemical protocols (if available) regarding the steps, reaction conditions, and scale. The review is structured according to the functional group formed in the reaction.
Collapse
Affiliation(s)
- Stefan Simić
- Institute of Chemistry, University of Graz, NAWI Graz, Heinrichstraße 28, 8010 Graz, Austria
| | - Erna Zukić
- Institute of Chemistry, University of Graz, NAWI Graz, Heinrichstraße 28, 8010 Graz, Austria
| | - Luca Schmermund
- Institute of Chemistry, University of Graz, NAWI Graz, Heinrichstraße 28, 8010 Graz, Austria
| | - Kurt Faber
- Institute of Chemistry, University of Graz, NAWI Graz, Heinrichstraße 28, 8010 Graz, Austria
| | - Christoph K Winkler
- Institute of Chemistry, University of Graz, NAWI Graz, Heinrichstraße 28, 8010 Graz, Austria
| | - Wolfgang Kroutil
- Institute of Chemistry, University of Graz, NAWI Graz, Heinrichstraße 28, 8010 Graz, Austria.,Field of Excellence BioHealth─University of Graz, 8010 Graz, Austria.,BioTechMed Graz, 8010 Graz, Austria
| |
Collapse
|
9
|
Nowrouzi B, Rios-Solis L. Redox metabolism for improving whole-cell P450-catalysed terpenoid biosynthesis. Crit Rev Biotechnol 2021; 42:1213-1237. [PMID: 34749553 DOI: 10.1080/07388551.2021.1990210] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
The growing preference for producing cytochrome P450-mediated natural products in microbial systems stems from the challenging nature of the organic chemistry approaches. The P450 enzymes are redox-dependent proteins, through which they source electrons from reducing cofactors to drive their activities. Widely researched in biochemistry, most of the previous studies have extensively utilised expensive cell-free assays to reveal mechanistic insights into P450 functionalities in presence of commercial redox partners. However, in the context of microbial bioproduction, the synergic activity of P450- reductase proteins in microbial systems have not been largely investigated. This is mainly due to limited knowledge about their mutual interactions in the context of complex systems. Hence, manipulating the redox potential for natural product synthesis in microbial chassis has been limited. As the potential of redox state as crucial regulator of P450 biocatalysis has been greatly underestimated by the scientific community, in this review, we re-emphasize their pivotal role in modulating the in vivo P450 activity through affecting the product profile and yield. Particularly, we discuss the applications of widely used in vivo redox engineering methodologies for natural product synthesis to provide further suggestions for patterning on P450-based terpenoids production in microbial platforms.
Collapse
Affiliation(s)
- Behnaz Nowrouzi
- Institute for Bioengineering, School of Engineering, The University of Edinburgh, Edinburgh, UK.,Centre for Synthetic and Systems Biology (SynthSys), The University of Edinburgh, Edinburgh, UK
| | - Leonardo Rios-Solis
- Institute for Bioengineering, School of Engineering, The University of Edinburgh, Edinburgh, UK.,Centre for Synthetic and Systems Biology (SynthSys), The University of Edinburgh, Edinburgh, UK
| |
Collapse
|
10
|
A Promiscuous Bacterial P450: The Unparalleled Diversity of BM3 in Pharmaceutical Metabolism. Int J Mol Sci 2021; 22:ijms222111380. [PMID: 34768811 PMCID: PMC8583553 DOI: 10.3390/ijms222111380] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2021] [Revised: 10/12/2021] [Accepted: 10/12/2021] [Indexed: 11/16/2022] Open
Abstract
CYP102A1 (BM3) is a catalytically self-sufficient flavocytochrome fusion protein isolated from Bacillus megaterium, which displays similar metabolic capabilities to many drug-metabolizing human P450 isoforms. BM3's high catalytic efficiency, ease of production and malleable active site makes the enzyme a desirable tool in the production of small molecule metabolites, especially for compounds that exhibit drug-like chemical properties. The engineering of select key residues within the BM3 active site vastly expands the catalytic repertoire, generating variants which can perform a range of modifications. This provides an attractive alternative route to the production of valuable compounds that are often laborious to synthesize via traditional organic means. Extensive studies have been conducted with the aim of engineering BM3 to expand metabolite production towards a comprehensive range of drug-like compounds, with many key examples found both in the literature and in the wider industrial bioproduction setting of desirable oxy-metabolite production by both wild-type BM3 and related variants. This review covers the past and current research on the engineering of BM3 to produce drug metabolites and highlights its crucial role in the future of biosynthetic pharmaceutical production.
Collapse
|
11
|
Grogan G. Hemoprotein Catalyzed Oxygenations: P450s, UPOs, and Progress toward Scalable Reactions. JACS AU 2021; 1:1312-1329. [PMID: 34604841 PMCID: PMC8479775 DOI: 10.1021/jacsau.1c00251] [Citation(s) in RCA: 33] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/04/2021] [Indexed: 05/15/2023]
Abstract
The selective oxygenation of nonactivated carbon atoms is an ongoing synthetic challenge, and biocatalysts, particularly hemoprotein oxygenases, continue to be investigated for their potential, given both their sustainable chemistry credentials and also their superior selectivity. However, issues of stability, activity, and complex reaction requirements often render these biocatalytic oxygenations problematic with respect to scalable industrial processes. A continuing focus on Cytochromes P450 (P450s), which require a reduced nicotinamide cofactor and redox protein partners for electron transport, has now led to better catalysts and processes with a greater understanding of process requirements and limitations for both in vitro and whole-cell systems. However, the discovery and development of unspecific peroxygenases (UPOs) has also recently provided valuable complementary technology to P450-catalyzed reactions. UPOs need only hydrogen peroxide to effect oxygenations but are hampered by their sensitivity to peroxide and also by limited selectivity. In this Perspective, we survey recent developments in the engineering of proteins, cells, and processes for oxygenations by these two groups of hemoproteins and evaluate their potential and relative merits for scalable reactions.
Collapse
|
12
|
Hall M. Enzymatic strategies for asymmetric synthesis. RSC Chem Biol 2021; 2:958-989. [PMID: 34458820 PMCID: PMC8341948 DOI: 10.1039/d1cb00080b] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2021] [Accepted: 05/28/2021] [Indexed: 12/13/2022] Open
Abstract
Enzymes, at the turn of the 21st century, are gaining a momentum. Especially in the field of synthetic organic chemistry, a broad variety of biocatalysts are being applied in an increasing number of processes running at up to industrial scale. In addition to the advantages of employing enzymes under environmentally friendly reaction conditions, synthetic chemists are recognizing the value of enzymes connected to the exquisite selectivity of these natural (or engineered) catalysts. The use of hydrolases in enantioselective protocols paved the way to the application of enzymes in asymmetric synthesis, in particular in the context of biocatalytic (dynamic) kinetic resolutions. After two decades of impressive development, the field is now mature to propose a panel of catalytically diverse enzymes for (i) stereoselective reactions with prochiral compounds, such as double bond reduction and bond forming reactions, (ii) formal enantioselective replacement of one of two enantiotopic groups of prochiral substrates, as well as (iii) atroposelective reactions with noncentrally chiral compounds. In this review, the major enzymatic strategies broadly applicable in the asymmetric synthesis of optically pure chiral compounds are presented, with a focus on the reactions developed within the past decade.
Collapse
Affiliation(s)
- Mélanie Hall
- Institute of Chemistry, University of Graz Heinrichstrasse 28 8010 Graz Austria
- Field of Excellence BioHealth - University of Graz Austria
| |
Collapse
|
13
|
Valikhani D, Bolivar JM, Pelletier JN. An Overview of Cytochrome P450 Immobilization Strategies for Drug Metabolism Studies, Biosensing, and Biocatalytic Applications: Challenges and Opportunities. ACS Catal 2021. [DOI: 10.1021/acscatal.1c02017] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Donya Valikhani
- Department of Chemistry, Université de Montréal and Center for Green Chemistry and Catalysis (CGCC), 1375 Thérèse-Lavoie-Roux Ave., Montréal, Quebec H2 V 0B3, Canada
- PROTEO, The Québec Network for Research on Protein Function, Engineering and Applications, Québec City Quebec G1 V 0A6, Canada
| | - Juan M. Bolivar
- Chemical and Materials Engineering Department, Faculty of Chemical Sciences, Complutense University of Madrid, Complutense Ave., 28040 Madrid, Spain
| | - Joelle N. Pelletier
- Department of Chemistry, Université de Montréal and Center for Green Chemistry and Catalysis (CGCC), 1375 Thérèse-Lavoie-Roux Ave., Montréal, Quebec H2 V 0B3, Canada
- PROTEO, The Québec Network for Research on Protein Function, Engineering and Applications, Québec City Quebec G1 V 0A6, Canada
- Department of Biochemistry, Université de Montréal, 2900 Édouard-Montpetit ave, Montréal, Quebec H3T 1J4, Canada
| |
Collapse
|
14
|
Tonin F, Tieves F, Willot S, van Troost A, van Oosten R, Breestraat S, van Pelt S, Alcalde M, Hollmann F. Pilot-Scale Production of Peroxygenase from Agrocybe aegerita. Org Process Res Dev 2021; 25:1414-1418. [PMID: 34168423 PMCID: PMC8218300 DOI: 10.1021/acs.oprd.1c00116] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2021] [Indexed: 12/17/2022]
Abstract
![]()
The pilot-scale production
of the peroxygenase from Agrocybe aegerita (rAaeUPO) is demonstrated.
In a fed-batch fermentation of the recombinant Pichia
pastoris, the enzyme was secreted into the culture
medium to a final concentration of 0.29 g L–1 corresponding
to 735 g of the peroxygenase in 2500 L of the fermentation broth after
6 days. Due to nonoptimized downstream processing, only 170 g of the
enzyme has been isolated. The preparative usefulness of the so-obtained
enzyme preparation has been demonstrated at a semipreparative scale
(100 mL) as an example of the stereoselective hydroxylation of ethyl
benzene. Using an adjusted H2O2 feed rate, linear
product formation was observed for 7 days, producing more than 5 g
L–1 (R)-1-phenyl ethanol. The biocatalyst
performed more than 340.000 catalytic turnovers (942 g of the product
per gram of rAaeUPO).
Collapse
Affiliation(s)
- Fabio Tonin
- Department of Biotechnology, Delft University of Technology, 2629HZ Delft, The Netherlands
| | - Florian Tieves
- Department of Biotechnology, Delft University of Technology, 2629HZ Delft, The Netherlands
| | - Sébastien Willot
- Department of Biotechnology, Delft University of Technology, 2629HZ Delft, The Netherlands
| | - Anouska van Troost
- Department of Biotechnology, Delft University of Technology, 2629HZ Delft, The Netherlands
| | - Remco van Oosten
- Department of Biotechnology, Delft University of Technology, 2629HZ Delft, The Netherlands
| | - Stefaan Breestraat
- Bioprocess Pilot Facility B.V., Alexander Fleminglaan 1, 2613 AX Delft, The Netherlands
| | - Sander van Pelt
- Bioprocess Pilot Facility B.V., Alexander Fleminglaan 1, 2613 AX Delft, The Netherlands
| | - Miguel Alcalde
- Department of Biocatalysis, Institute of Catalysis, CSIC, Cantoblanco, 28049 Madrid, Spain
| | - Frank Hollmann
- Department of Biotechnology, Delft University of Technology, 2629HZ Delft, The Netherlands
| |
Collapse
|
15
|
Optimization and Engineering of a Self-Sufficient CYP102 Enzyme from Bacillus amyloliquefaciens towards Synthesis of In-Chain Hydroxy Fatty Acids. Catalysts 2021. [DOI: 10.3390/catal11060665] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Cytochrome P450 (CYP) mediated enzymatic hydroxylation of fatty acids present a green alternative to chemical synthesis of hydroxy fatty acids (HFAs), which are high-value oleochemicals with various uses in materials industry and medical field. Although many CYPs require the presence of additional reductase proteins for catalytic activity, self-sufficient CYPs have their reductase partner naturally fused into their catalytic domain, leading to a greatly simplified biotransformation process. A recently discovered self-sufficient CYP, BAMF2522 from Bacillus amyloliquefaciens DSM 7, exhibits novel regioselectivity by hydroxylating in-chain positions of palmitic acid generating ω-1 to ω-7 HFAs, a rare regiodiversity profile among CYPs. Besides, F89I mutant of BAMF2522 expanded hydroxylation up to ω-9 position of palmitic acid. Here, we further characterize this enzyme by determining optimum temperature and pH as well as thermal stability. Moreover, using extensive site-directed and site-saturation mutagenesis, we obtained BAMF2522 variants that demonstrate greatly increased regioselectivity for in-chain positions (ω-4 to ω-9) of various medium to long chain fatty acids. Remarkably, when a six-residue mutant was reacted with palmitic acid, 84% of total product content was the sum of ω-7, ω-8 and ω-9 HFA products, the highest in-chain selectivity observed to date with a self-sufficient CYP. In short, our study demonstrates the potential of a recently identified CYP and its mutants for green and sustainable production of a variety of in-chain hydroxy enriched HFAs.
Collapse
|
16
|
Advances in enzymatic oxyfunctionalization of aliphatic compounds. Biotechnol Adv 2021; 51:107703. [PMID: 33545329 DOI: 10.1016/j.biotechadv.2021.107703] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2020] [Revised: 01/17/2021] [Accepted: 01/25/2021] [Indexed: 12/27/2022]
Abstract
Selective oxyfunctionalizations of aliphatic compounds are difficult chemical reactions, where enzymes can play an important role due to their stereo- and regio-selectivity and operation under mild reaction conditions. P450 monooxygenases are well-known biocatalysts that mediate oxyfunctionalization reactions in different living organisms (from bacteria to humans). Unspecific peroxygenases (UPOs), discovered in fungi, have arisen as "dream biocatalysts" of great biotechnological interest because they catalyze the oxyfunctionalization of aliphatic and aromatic compounds, avoiding the necessity of expensive cofactors and regeneration systems, and only depending on H2O2 for their catalysis. Here, we summarize recent advances in aliphatic oxyfunctionalization reactions by UPOs, as well as the molecular determinants of the enzyme structures responsible for their activities, emphasizing the differences found between well-known P450s and the novel fungal peroxygenases.
Collapse
|
17
|
Ionic liquids for regulating biocatalytic process: Achievements and perspectives. Biotechnol Adv 2021; 51:107702. [PMID: 33515671 DOI: 10.1016/j.biotechadv.2021.107702] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2020] [Revised: 12/26/2020] [Accepted: 01/15/2021] [Indexed: 12/26/2022]
Abstract
Biocatalysis has found enormous applications in sorts of fields as an alternative to chemical catalysis. In the pursue of green and sustainable chemistry, ionic liquids (ILs) have been considered as promising reaction media for biocatalysis, owing to their unique characteristics, such as nonvolatility, inflammability and tunable properties as regards polarity and water miscibility behavior, compared to organic solvents. In recent years, great developments have been achieved in respects to biocatalysis in ILs, especially for preparing various chemicals. This review tends to give illustrative examples with a focus on representative chemicals production by biocatalyst in ILs and elucidate the possible mechanism in such systems. It also discusses how to regulate the catalytic efficiency from several aspects and finally provides an outlook on the opportunities to broaden biocatalysis in ILs.
Collapse
|
18
|
Wu S, Snajdrova R, Moore JC, Baldenius K, Bornscheuer UT. Biocatalysis: Enzymatic Synthesis for Industrial Applications. Angew Chem Int Ed Engl 2021; 60:88-119. [PMID: 32558088 PMCID: PMC7818486 DOI: 10.1002/anie.202006648] [Citation(s) in RCA: 522] [Impact Index Per Article: 174.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Indexed: 12/12/2022]
Abstract
Biocatalysis has found numerous applications in various fields as an alternative to chemical catalysis. The use of enzymes in organic synthesis, especially to make chiral compounds for pharmaceuticals as well for the flavors and fragrance industry, are the most prominent examples. In addition, biocatalysts are used on a large scale to make specialty and even bulk chemicals. This review intends to give illustrative examples in this field with a special focus on scalable chemical production using enzymes. It also discusses the opportunities and limitations of enzymatic syntheses using distinct examples and provides an outlook on emerging enzyme classes.
Collapse
Affiliation(s)
- Shuke Wu
- Institute of BiochemistryDept. of Biotechnology & Enzyme CatalysisGreifswald UniversityFelix-Hausdorff-Strasse 417487GreifswaldGermany
| | - Radka Snajdrova
- Novartis Institutes for BioMedical ResearchGlobal Discovery Chemistry4056BaselSwitzerland
| | - Jeffrey C. Moore
- Process Research and DevelopmentMerck & Co., Inc.126 E. Lincoln AveRahwayNJ07065USA
| | - Kai Baldenius
- Baldenius Biotech ConsultingHafenstr. 3168159MannheimGermany
| | - Uwe T. Bornscheuer
- Institute of BiochemistryDept. of Biotechnology & Enzyme CatalysisGreifswald UniversityFelix-Hausdorff-Strasse 417487GreifswaldGermany
| |
Collapse
|
19
|
Slagman S, Fessner WD. Biocatalytic routes to anti-viral agents and their synthetic intermediates. Chem Soc Rev 2021; 50:1968-2009. [DOI: 10.1039/d0cs00763c] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
An assessment of biocatalytic strategies for the synthesis of anti-viral agents, offering guidelines for the development of sustainable production methods for a future COVID-19 remedy.
Collapse
Affiliation(s)
- Sjoerd Slagman
- Institut für Organische Chemie und Biochemie
- Technische Universität Darmstadt
- Germany
| | - Wolf-Dieter Fessner
- Institut für Organische Chemie und Biochemie
- Technische Universität Darmstadt
- Germany
| |
Collapse
|
20
|
Qin L, Wu L, Nie Y, Xu Y. Biosynthesis of chiral cyclic and heterocyclic alcohols via CO/C–H/C–O asymmetric reactions. Catal Sci Technol 2021. [DOI: 10.1039/d1cy00113b] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
This review covers the recent progress in various biological approaches applied to the synthesis of enantiomerically pure cyclic and heterocyclic alcohols through CO/C–H/C–O asymmetric reactions.
Collapse
Affiliation(s)
- Lei Qin
- School of Biotechnology and Key Laboratory of Industrial Biotechnology of Ministry of Education
- Jiangnan University
- Wuxi 214122
- China
| | - Lunjie Wu
- School of Biotechnology and Key Laboratory of Industrial Biotechnology of Ministry of Education
- Jiangnan University
- Wuxi 214122
- China
| | - Yao Nie
- School of Biotechnology and Key Laboratory of Industrial Biotechnology of Ministry of Education
- Jiangnan University
- Wuxi 214122
- China
- International Joint Research Laboratory for Brewing Microbiology and Applied Enzymology at Jiangnan University
| | - Yan Xu
- School of Biotechnology and Key Laboratory of Industrial Biotechnology of Ministry of Education
- Jiangnan University
- Wuxi 214122
- China
- International Joint Research Laboratory for Brewing Microbiology and Applied Enzymology at Jiangnan University
| |
Collapse
|
21
|
Chakrabarty S, Wang Y, Perkins JC, Narayan ARH. Scalable biocatalytic C-H oxyfunctionalization reactions. Chem Soc Rev 2020; 49:8137-8155. [PMID: 32701110 PMCID: PMC8177087 DOI: 10.1039/d0cs00440e] [Citation(s) in RCA: 80] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Catalytic C-H oxyfunctionalization reactions have garnered significant attention in recent years with their ability to streamline synthetic routes toward complex molecules. Consequently, there have been significant strides in the design and development of catalysts that enable diversification through C-H functionalization reactions. Enzymatic C-H oxygenation reactions are often complementary to small molecule based synthetic approaches, providing a powerful tool when deployable on preparative-scale. This review highlights key advances in scalable biocatalytic C-H oxyfunctionalization reactions developed within the past decade.
Collapse
Affiliation(s)
- Suman Chakrabarty
- Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA.
| | | | | | | |
Collapse
|
22
|
Decembrino D, Ricklefs E, Wohlgemuth S, Girhard M, Schullehner K, Jach G, Urlacher VB. Assembly of Plant Enzymes in E. coli for the Production of the Valuable (-)-Podophyllotoxin Precursor (-)-Pluviatolide. ACS Synth Biol 2020; 9:3091-3103. [PMID: 33095000 DOI: 10.1021/acssynbio.0c00354] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Lignans are plant secondary metabolites with a wide range of reported health-promoting bioactivities. Traditional routes toward these natural products involve, among others, the extraction from plant sources and chemical synthesis. However, the availability of the sources and the complex chemical structures of lignans often limit the feasibility of these approaches. In this work, we introduce a newly assembled biosynthetic route in E. coli for the efficient conversion of the common higher-lignan precursor (+)-pinoresinol to the noncommercially available (-)-pluviatolide via three intermediates. (-)-Pluviatolide is considered a crossroad compound in lignan biosynthesis, because the methylenedioxy bridge in its structure, resulting from the oxidation of (-)-matairesinol, channels the biosynthetic pathway toward the microtubule depolymerizer (-)-podophyllotoxin. This oxidation reaction is catalyzed with high regio- and enantioselectivity by a cytochrome P450 monooxygenase from Sinopodophyllum hexandrum (CYP719A23), which was expressed and optimized regarding redox partners in E. coli. Pinoresinol-lariciresinol reductase from Forsythia intermedia (FiPLR), secoisolariciresinol dehydrogenase from Podophyllum pleianthum (PpSDH), and CYP719A23 were coexpressed together with a suitable NADPH-dependent reductase to ensure P450 activity, allowing for four sequential biotransformations without intermediate isolation. By using an E. coli strain coexpressing the enzymes originating from four plants, (+)-pinoresinol was efficiently converted, allowing the isolation of enantiopure (-)-pluviatolide at a concentration of 137 mg/L (ee ≥99% with 76% isolated yield).
Collapse
Affiliation(s)
- Davide Decembrino
- Institute of Biochemistry, Heinrich-Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany
| | - Esther Ricklefs
- Institute of Biochemistry, Heinrich-Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany
| | - Stefan Wohlgemuth
- Institute of Biochemistry, Heinrich-Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany
| | - Marco Girhard
- Institute of Biochemistry, Heinrich-Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany
| | - Katrin Schullehner
- Phytowelt Green Technologies GmbH, Kölsumer Weg 33, 41334 Nettetal, Germany
| | - Guido Jach
- Phytowelt Green Technologies GmbH, Kölsumer Weg 33, 41334 Nettetal, Germany
| | - Vlada B. Urlacher
- Institute of Biochemistry, Heinrich-Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany
| |
Collapse
|
23
|
Wu S, Snajdrova R, Moore JC, Baldenius K, Bornscheuer UT. Biokatalyse: Enzymatische Synthese für industrielle Anwendungen. Angew Chem Int Ed Engl 2020. [DOI: 10.1002/ange.202006648] [Citation(s) in RCA: 62] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Shuke Wu
- Institut für Biochemie Abt. Biotechnologie & Enzymkatalyse Universität Greifswald Felix-Hausdorff-Straße 4 17487 Greifswald Deutschland
| | - Radka Snajdrova
- Novartis Institutes for BioMedical Research Global Discovery Chemistry 4056 Basel Schweiz
| | - Jeffrey C. Moore
- Process Research and Development Merck & Co., Inc. 126 E. Lincoln Ave Rahway NJ 07065 USA
| | - Kai Baldenius
- Baldenius Biotech Consulting Hafenstraße 31 68159 Mannheim Deutschland
| | - Uwe T. Bornscheuer
- Institut für Biochemie Abt. Biotechnologie & Enzymkatalyse Universität Greifswald Felix-Hausdorff-Straße 4 17487 Greifswald Deutschland
| |
Collapse
|
24
|
Chen W, Fisher MJ, Leung A, Cao Y, Wong LL. Oxidative Diversification of Steroids by Nature-Inspired Scanning Glycine Mutagenesis of P450BM3 (CYP102A1). ACS Catal 2020. [DOI: 10.1021/acscatal.0c02077] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Wenyu Chen
- Department of Chemistry, University of Oxford, Inorganic Chemistry Laboratory, South Parks Road, Oxford OX1 3QR, U.K
| | - Matthew J. Fisher
- Department of Chemistry, University of Oxford, Inorganic Chemistry Laboratory, South Parks Road, Oxford OX1 3QR, U.K
| | - Aaron Leung
- Department of Chemistry, University of Oxford, Inorganic Chemistry Laboratory, South Parks Road, Oxford OX1 3QR, U.K
| | - Yang Cao
- Department of Chemistry, University of Oxford, Inorganic Chemistry Laboratory, South Parks Road, Oxford OX1 3QR, U.K
- Oxford Suzhou Centre for Advanced Research, Ruo Shui Road, Suzhou Industrial Park, Jiangsu 215123, P.R. China
| | - Luet L. Wong
- Department of Chemistry, University of Oxford, Inorganic Chemistry Laboratory, South Parks Road, Oxford OX1 3QR, U.K
- Oxford Suzhou Centre for Advanced Research, Ruo Shui Road, Suzhou Industrial Park, Jiangsu 215123, P.R. China
| |
Collapse
|
25
|
Lall MS, Bassyouni A, Bradow J, Brown M, Bundesmann M, Chen J, Ciszewski G, Hagen AE, Hyek D, Jenkinson S, Liu B, Obach RS, Pan S, Reilly U, Sach N, Smaltz DJ, Spracklin DK, Starr J, Wagenaar M, Walker GS. Late-Stage Lead Diversification Coupled with Quantitative Nuclear Magnetic Resonance Spectroscopy to Identify New Structure–Activity Relationship Vectors at Nanomole-Scale Synthesis: Application to Loratadine, a Human Histamine H1 Receptor Inverse Agonist. J Med Chem 2020; 63:7268-7292. [DOI: 10.1021/acs.jmedchem.0c00483] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Affiliation(s)
- Manjinder S. Lall
- Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Asser Bassyouni
- Pfizer Worldwide Research and Development, Science Center Drive, San Diego, California 92121, United States
| | - James Bradow
- Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Maria Brown
- Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Mark Bundesmann
- Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Jinshan Chen
- Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Gregory Ciszewski
- Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Anne E. Hagen
- Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Dennis Hyek
- Spectrix Analytical Services, LLC, 410 Sackett Point Road, Bldg 20, North Haven, Connecticut 06473, United States
| | - Stephen Jenkinson
- Pfizer Worldwide Research and Development, Science Center Drive, San Diego, California 92121, United States
| | - Bo Liu
- Spectrix Analytical Services, LLC, 410 Sackett Point Road, Bldg 20, North Haven, Connecticut 06473, United States
| | - R. Scott Obach
- Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Senliang Pan
- Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Usa Reilly
- Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Neal Sach
- Pfizer Worldwide Research and Development, Science Center Drive, San Diego, California 92121, United States
| | - Daniel J. Smaltz
- Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States
| | - Douglas K. Spracklin
- Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Jeremy Starr
- Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Melissa Wagenaar
- Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Gregory S. Walker
- Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| |
Collapse
|
26
|
Buergler MB, Dennig A, Nidetzky B. Process intensification for cytochrome P450 BM3-catalyzed oxy-functionalization of dodecanoic acid. Biotechnol Bioeng 2020; 117:2377-2388. [PMID: 32369187 PMCID: PMC7384007 DOI: 10.1002/bit.27372] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2020] [Revised: 05/01/2020] [Accepted: 05/03/2020] [Indexed: 01/15/2023]
Abstract
Selective oxy‐functionalization of nonactivated C‐H bonds is a long‐standing “dream reaction” of organic synthesis for which chemical methodology is not well developed. Mono‐oxygenase enzymes are promising catalysts for such oxy‐functionalization to establish. Limitation on their applicability arises from low reaction output. Here, we showed an integrated approach of process engineering to the intensification of the cytochrome P450 BM3‐catalyzed hydroxylation of dodecanoic acid (C12:0). Using P450 BM3 together with glucose dehydrogenase for regeneration of nicotinamide adenine dinucleotide phosphate (NADPH), we compared soluble and co‐immobilized enzymes in O2‐gassed and pH‐controlled conversions at high final substrate concentrations (≥40mM). We identified the main engineering parameters of process output (i.e., O2 supply; mixing correlated with immobilized enzyme stability; foam control correlated with product isolation; substrate solubilization) and succeeded in disentangling their complex interrelationship for systematic process optimization. Running the reaction at O2‐limited conditions at up to 500‐ml scale (10% dimethyl sulfoxide; silicone antifoam), we developed a substrate feeding strategy based on O2 feedback control. Thus, we achieved high reaction rates of 1.86g·L−1·hr−1 and near complete conversion (≥90%) of 80mM (16g/L) C12:0 with good selectivity (≤5% overoxidation). We showed that “uncoupled reaction” of the P450 BM3 (~95% utilization of NADPH and O2 not leading to hydroxylation) with the C12:0 hydroxylated product limited the process efficiency at high product concentration. Hydroxylated product (~7g; ≥92% purity) was recovered from 500ml reaction in 82% yield using ethyl‐acetate extraction. Collectively, these results demonstrate key engineering parameters for the biocatalytic oxy‐functionalization and show their integration into a coherent strategy for process intensification.
Collapse
Affiliation(s)
- Moritz B Buergler
- Institute of Biotechnology and Biochemical Engineering, Graz University of Technology, Graz, Austria
| | - Alexander Dennig
- Institute of Biotechnology and Biochemical Engineering, Graz University of Technology, Graz, Austria.,Austrian Centre of Industrial Biotechnology, Graz, Austria
| | - Bernd Nidetzky
- Institute of Biotechnology and Biochemical Engineering, Graz University of Technology, Graz, Austria.,Austrian Centre of Industrial Biotechnology, Graz, Austria
| |
Collapse
|
27
|
Wiltschi B, Cernava T, Dennig A, Galindo Casas M, Geier M, Gruber S, Haberbauer M, Heidinger P, Herrero Acero E, Kratzer R, Luley-Goedl C, Müller CA, Pitzer J, Ribitsch D, Sauer M, Schmölzer K, Schnitzhofer W, Sensen CW, Soh J, Steiner K, Winkler CK, Winkler M, Wriessnegger T. Enzymes revolutionize the bioproduction of value-added compounds: From enzyme discovery to special applications. Biotechnol Adv 2020; 40:107520. [DOI: 10.1016/j.biotechadv.2020.107520] [Citation(s) in RCA: 55] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2019] [Revised: 10/18/2019] [Accepted: 01/13/2020] [Indexed: 12/11/2022]
|
28
|
Freakley SJ, Kochius S, van Marwijk J, Fenner C, Lewis RJ, Baldenius K, Marais SS, Opperman DJ, Harrison STL, Alcalde M, Smit MS, Hutchings GJ. A chemo-enzymatic oxidation cascade to activate C-H bonds with in situ generated H 2O 2. Nat Commun 2019; 10:4178. [PMID: 31519878 PMCID: PMC6744418 DOI: 10.1038/s41467-019-12120-w] [Citation(s) in RCA: 44] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2019] [Accepted: 08/16/2019] [Indexed: 11/09/2022] Open
Abstract
Continuous low-level supply or in situ generation of hydrogen peroxide (H2O2) is essential for the stability of unspecific peroxygenases, which are deemed ideal biocatalysts for the selective activation of C-H bonds. To envisage potential large scale applications of combined catalytic systems the reactions need to be simple, efficient and produce minimal by-products. We show that gold-palladium nanoparticles supported on TiO2 or carbon have sufficient activity at ambient temperature and pressure to generate H2O2 from H2 and O2 and supply the oxidant to the engineered unspecific heme-thiolate peroxygenase PaDa-I. This tandem catalyst combination facilitates efficient oxidation of a range of C-H bonds to hydroxylated products in one reaction vessel with only water as a by-product under conditions that could be easily scaled.
Collapse
Affiliation(s)
- Simon J Freakley
- Cardiff Catalysis Institute, School of Chemistry, Cardiff University, Main Building, Park Place, Cardiff, CF10 3AT, UK
- Department of Chemistry, University of Bath, Claverton Down, Bath, BA2 7AY, UK
| | - Svenja Kochius
- Department of Microbial, Biochemical and Food Biotechnology, University of the Free State, Bloemfontein, South Africa
- South African DST-NRF Centre of Excellence in Catalysis, C*Change, University of Cape Town, Private Bag, Rondebosch, 7701, Cape Town, South Africa
| | - Jacqueline van Marwijk
- Department of Microbial, Biochemical and Food Biotechnology, University of the Free State, Bloemfontein, South Africa
- South African DST-NRF Centre of Excellence in Catalysis, C*Change, University of Cape Town, Private Bag, Rondebosch, 7701, Cape Town, South Africa
| | - Caryn Fenner
- South African DST-NRF Centre of Excellence in Catalysis, C*Change, University of Cape Town, Private Bag, Rondebosch, 7701, Cape Town, South Africa
- Centre for Bioprocess Engineering Research (CeBER), Department of Chemical Engineering, University of Cape Town, Private Bag X3, Rondebosch, 7701, Cape Town, South Africa
| | - Richard J Lewis
- Cardiff Catalysis Institute, School of Chemistry, Cardiff University, Main Building, Park Place, Cardiff, CF10 3AT, UK
| | - Kai Baldenius
- BASF SE, RBW/OS - A 30, Carl-Bosch-Strasse 38, 67056, Ludwigshafen am Rhein, Germany
| | - Sarel S Marais
- Department of Microbial, Biochemical and Food Biotechnology, University of the Free State, Bloemfontein, South Africa
- South African DST-NRF Centre of Excellence in Catalysis, C*Change, University of Cape Town, Private Bag, Rondebosch, 7701, Cape Town, South Africa
| | - Diederik J Opperman
- Department of Microbial, Biochemical and Food Biotechnology, University of the Free State, Bloemfontein, South Africa
- South African DST-NRF Centre of Excellence in Catalysis, C*Change, University of Cape Town, Private Bag, Rondebosch, 7701, Cape Town, South Africa
| | - Susan T L Harrison
- South African DST-NRF Centre of Excellence in Catalysis, C*Change, University of Cape Town, Private Bag, Rondebosch, 7701, Cape Town, South Africa
- Centre for Bioprocess Engineering Research (CeBER), Department of Chemical Engineering, University of Cape Town, Private Bag X3, Rondebosch, 7701, Cape Town, South Africa
| | - Miguel Alcalde
- Department of Biocatalysis, Institute of Catalysis, CSIC, 28049, Madrid, Spain
| | - Martha S Smit
- Department of Microbial, Biochemical and Food Biotechnology, University of the Free State, Bloemfontein, South Africa.
- South African DST-NRF Centre of Excellence in Catalysis, C*Change, University of Cape Town, Private Bag, Rondebosch, 7701, Cape Town, South Africa.
| | - Graham J Hutchings
- Cardiff Catalysis Institute, School of Chemistry, Cardiff University, Main Building, Park Place, Cardiff, CF10 3AT, UK.
| |
Collapse
|
29
|
Solé J, Brummund J, Caminal G, Schürman M, Álvaro G, Guillén M. Ketoisophorone Synthesis with an Immobilized Alcohol Dehydrogenase. ChemCatChem 2019. [DOI: 10.1002/cctc.201901090] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Jordi Solé
- Departament d'enginyeria Química, Biològica i AmbientalUniversitat Autònoma de Barcelona Carrer de les Sitges s/n, Escola d'enginyeria 08193 Barcelona Spain
| | - Jan Brummund
- InnoSyn B.V. Urmonderbaan 22 6167 RD Geleen The Nederlands
| | - Glòria Caminal
- Institut de Química Avançada de Catalunya (IQAC) Carrer de Jordi Girona 20 08034 Barcelona Spain
| | | | - Gregorio Álvaro
- Departament d'enginyeria Química, Biològica i AmbientalUniversitat Autònoma de Barcelona Carrer de les Sitges s/n, Escola d'enginyeria 08193 Barcelona Spain
| | - Marina Guillén
- Departament d'enginyeria Química, Biològica i AmbientalUniversitat Autònoma de Barcelona Carrer de les Sitges s/n, Escola d'enginyeria 08193 Barcelona Spain
| |
Collapse
|
30
|
Santos GDA, Dhoke GV, Davari MD, Ruff AJ, Schwaneberg U. Directed Evolution of P450 BM3 towards Functionalization of Aromatic O-Heterocycles. Int J Mol Sci 2019; 20:E3353. [PMID: 31288417 PMCID: PMC6651506 DOI: 10.3390/ijms20133353] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2019] [Revised: 06/28/2019] [Accepted: 07/01/2019] [Indexed: 02/04/2023] Open
Abstract
The O-heterocycles, benzo-1,4-dioxane, phthalan, isochroman, 2,3-dihydrobenzofuran, benzofuran, and dibenzofuran are important building blocks with considerable medical application for the production of pharmaceuticals. Cytochrome P450 monooxygenase (P450) Bacillus megaterium 3 (BM3) wild type (WT) from Bacillus megaterium has low to no conversion of the six O-heterocycles. Screening of in-house libraries for active variants yielded P450 BM3 CM1 (R255P/P329H), which was subjected to directed evolution and site saturation mutagenesis of four positions. The latter led to the identification of position R255, which when introduced in the P450 BM3 WT, outperformed all other variants. The initial oxidation rate of nicotinamide adenine dinucleotide phosphate (NADPH) consumption increased ≈140-fold (WT: 8.3 ± 1.3 min-1; R255L: 1168 ± 163 min-1), total turnover number (TTN) increased ≈21-fold (WT: 40 ± 3; R255L: 860 ± 15), and coupling efficiency, ≈2.9-fold (WT: 8.8 ± 0.1%; R255L: 25.7 ± 1.0%). Computational analysis showed that substitution R255L (distant from the heme-cofactor) does not have the salt bridge formed with D217 in WT, which introduces flexibility into the I-helix and leads to a heme rearrangement allowing for efficient hydroxylation.
Collapse
Affiliation(s)
| | - Gaurao V Dhoke
- Lehrstuhl für Biotechnologie, RWTH Aachen University, Worringerweg 3, 52074 Aachen, Germany
| | - Mehdi D Davari
- Lehrstuhl für Biotechnologie, RWTH Aachen University, Worringerweg 3, 52074 Aachen, Germany
| | - Anna Joëlle Ruff
- Lehrstuhl für Biotechnologie, RWTH Aachen University, Worringerweg 3, 52074 Aachen, Germany
| | - Ulrich Schwaneberg
- Lehrstuhl für Biotechnologie, RWTH Aachen University, Worringerweg 3, 52074 Aachen, Germany.
- DWI-Leibniz-Institut für Interaktive Materialien e.V., Forckenbeckstraße 50, 52074 Aachen, Germany.
| |
Collapse
|
31
|
Li Y, Wong LL. Multi‐Functional Oxidase Activity of CYP102A1 (P450BM3) in the Oxidation of Quinolines and Tetrahydroquinolines. Angew Chem Int Ed Engl 2019; 58:9551-9555. [DOI: 10.1002/anie.201904157] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2019] [Revised: 05/13/2019] [Indexed: 11/06/2022]
Affiliation(s)
- Yushu Li
- Department of ChemistryUniversity of OxfordInorganic Chemistry Laboratory South Parks Road Oxford OX1 3QR UK
| | - Luet L. Wong
- Department of ChemistryUniversity of OxfordInorganic Chemistry Laboratory South Parks Road Oxford OX1 3QR UK
- Oxford Suzhou Centre for Advanced Research Ruo Shui Road, Suzhou Industrial Park Jiangsu 215123 P. R. China
| |
Collapse
|
32
|
Li Y, Wong LL. Multi‐Functional Oxidase Activity of CYP102A1 (P450BM3) in the Oxidation of Quinolines and Tetrahydroquinolines. Angew Chem Int Ed Engl 2019. [DOI: 10.1002/ange.201904157] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Yushu Li
- Department of ChemistryUniversity of OxfordInorganic Chemistry Laboratory South Parks Road Oxford OX1 3QR UK
| | - Luet L. Wong
- Department of ChemistryUniversity of OxfordInorganic Chemistry Laboratory South Parks Road Oxford OX1 3QR UK
- Oxford Suzhou Centre for Advanced Research Ruo Shui Road, Suzhou Industrial Park Jiangsu 215123 P. R. China
| |
Collapse
|
33
|
Adams JP, Brown MJB, Diaz‐Rodriguez A, Lloyd RC, Roiban G. Biocatalysis: A Pharma Perspective. Adv Synth Catal 2019. [DOI: 10.1002/adsc.201900424] [Citation(s) in RCA: 66] [Impact Index Per Article: 13.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Affiliation(s)
- Joseph P. Adams
- API Chemistry, Medicinal Science and TechnologyPharma R&D, GlaxoSmithKline Medicines Research Centre Gunnels Wood Road, Stevenage SG12NY U.K
| | - Murray J. B. Brown
- Synthetic Biochemistry, Medicinal Science and TechnologyPharma R&D, GlaxoSmithKline Medicines Research Centre Gunnels Wood Road, Stevenage SG12NY U.K
| | - Alba Diaz‐Rodriguez
- API Chemistry, Medicinal Science and TechnologyPharma R&D, GlaxoSmithKline Medicines Research Centre Gunnels Wood Road, Stevenage SG12NY U.K
| | - Richard C. Lloyd
- API Chemistry, Medicinal Science and TechnologyPharma R&D, GlaxoSmithKline Medicines Research Centre Gunnels Wood Road, Stevenage SG12NY U.K
| | - Gheorghe‐Doru Roiban
- Synthetic Biochemistry, Medicinal Science and TechnologyPharma R&D, GlaxoSmithKline Medicines Research Centre Gunnels Wood Road, Stevenage SG12NY U.K
| |
Collapse
|
34
|
Sterckx H, Morel B, Maes BUW. Catalytic Aerobic Oxidation of C(sp 3 )-H Bonds. Angew Chem Int Ed Engl 2019; 58:7946-7970. [PMID: 30052305 DOI: 10.1002/anie.201804946] [Citation(s) in RCA: 144] [Impact Index Per Article: 28.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2018] [Indexed: 01/04/2023]
Abstract
Oxidation reactions are a key technology to transform hydrocarbons from petroleum feedstock into chemicals of a higher oxidation state, allowing further chemical transformations. These bulk-scale oxidation processes usually employ molecular oxygen as the terminal oxidant as at this scale it is typically the only economically viable oxidant. The produced commodity chemicals possess limited functionality and usually show a high degree of symmetry thereby avoiding selectivity issues. In sharp contrast, in the production of fine chemicals preference is still given to classical oxidants. Considering the strive for greener production processes, the use of O2 , the most abundant and greenest oxidant, is a logical choice. Given the rich functionality and complexity of fine chemicals, achieving regio/chemoselectivity is a major challenge. This review presents an overview of the most important catalytic systems recently described for aerobic oxidation, and the current insight in their reaction mechanism.
Collapse
Affiliation(s)
- Hans Sterckx
- Department of Chemistry, University of Antwerp, Groenenborgerlaan 171, B-2020, Antwerp, Belgium
| | - Bénédicte Morel
- Department of Chemistry, University of Antwerp, Groenenborgerlaan 171, B-2020, Antwerp, Belgium
| | - Bert U W Maes
- Department of Chemistry, University of Antwerp, Groenenborgerlaan 171, B-2020, Antwerp, Belgium
| |
Collapse
|
35
|
Sterckx H, Morel B, Maes BUW. Katalytische, aerobe Oxidation von C(sp
3
)‐H‐Bindungen. Angew Chem Int Ed Engl 2019. [DOI: 10.1002/ange.201804946] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Affiliation(s)
- Hans Sterckx
- Department of Chemistry University of Antwerp Groenenborgerlaan 171 B-2020 Antwerpen Belgien
| | - Bénédicte Morel
- Department of Chemistry University of Antwerp Groenenborgerlaan 171 B-2020 Antwerpen Belgien
| | - Bert U. W. Maes
- Department of Chemistry University of Antwerp Groenenborgerlaan 171 B-2020 Antwerpen Belgien
| |
Collapse
|
36
|
Recent preparative applications of redox enzymes. Curr Opin Chem Biol 2019; 49:105-112. [DOI: 10.1016/j.cbpa.2018.11.011] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2018] [Revised: 11/12/2018] [Accepted: 11/13/2018] [Indexed: 01/02/2023]
|
37
|
Aranda C, Municoy M, Guallar V, Kiebist J, Scheibner K, Ullrich R, del Río JC, Hofrichter M, Martínez AT, Gutiérrez A. Selective synthesis of 4-hydroxyisophorone and 4-ketoisophorone by fungal peroxygenases. Catal Sci Technol 2019. [DOI: 10.1039/c8cy02114g] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Some fungal peroxygenases (UPOs) selectively oxidize α-isophorone to 4-hydroxyisophorone (4HIP) and 4-ketoisophorone (4KIP) while others are less selective or unable.
Collapse
Affiliation(s)
- Carmen Aranda
- Instituto de Recursos Naturales y Agrobiología de Sevilla
- CSIC
- E-41012 Seville
- Spain
| | | | - Víctor Guallar
- Barcelona Supercomputing Center
- Barcelona
- Spain
- ICREA Passeig Lluís Companys 23
- Barcelona
| | | | | | - René Ullrich
- TU Dresden
- Department of Bio- and Environmental Sciences
- 02763 Zittau
- Germany
| | - José C. del Río
- Instituto de Recursos Naturales y Agrobiología de Sevilla
- CSIC
- E-41012 Seville
- Spain
| | - Martin Hofrichter
- TU Dresden
- Department of Bio- and Environmental Sciences
- 02763 Zittau
- Germany
| | | | - Ana Gutiérrez
- Instituto de Recursos Naturales y Agrobiología de Sevilla
- CSIC
- E-41012 Seville
- Spain
| |
Collapse
|
38
|
Baker Dockrey SA, Doyon TJ, Perkins JC, Narayan ARH. Whole-cell biocatalysis platform for gram-scale oxidative dearomatization of phenols. Chem Biol Drug Des 2018; 93:1207-1213. [PMID: 30485666 DOI: 10.1111/cbdd.13443] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2018] [Revised: 10/04/2018] [Accepted: 10/27/2018] [Indexed: 12/01/2022]
Abstract
Technologies enabling new enzyme discovery and efficient protein engineering have spurred intense interest in the development of biocatalytic reactions. In recent years, whole-cell biocatalysis has received attention as a simple, efficient, and scalable biocatalytic reaction platform. Inspired by these developments, we have established a whole-cell protocol for oxidative dearomatization of phenols using the flavin-dependent monooxygenase, TropB. This approach provides a scalable biocatalytic platform for accessing gram-scale quantities of chiral synthetic building blocks.
Collapse
Affiliation(s)
- Summer A Baker Dockrey
- Life Sciences Institute, University of Michigan, Ann Arbor, Michigan.,Department of Chemistry, University of Michigan, Ann Arbor, Michigan
| | - Tyler J Doyon
- Life Sciences Institute, University of Michigan, Ann Arbor, Michigan.,Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan
| | - Jonathan C Perkins
- Life Sciences Institute, University of Michigan, Ann Arbor, Michigan.,Department of Chemistry, University of Michigan, Ann Arbor, Michigan
| | - Alison R H Narayan
- Life Sciences Institute, University of Michigan, Ann Arbor, Michigan.,Department of Chemistry, University of Michigan, Ann Arbor, Michigan.,Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan
| |
Collapse
|
39
|
Syntrivanis LD, Wong LL, Robertson J. Hydroxylation of Eleuthoside Synthetic Intermediates by P450BM3
(CYP102A1). European J Org Chem 2018. [DOI: 10.1002/ejoc.201801206] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
| | - Luet Lok Wong
- Department of Chemistry; Inorganic Chemistry Laboratory; University of Oxford; South Parks Road 3QR Oxford, OX1 UK
| | - Jeremy Robertson
- Department of Chemistry; Chemistry Research Laboratory; University of Oxford; Mansfield Road 3TA (UK) Oxford, OX1
| |
Collapse
|
40
|
Valikhani D, Bolivar JM, Dennig A, Nidetzky B. A tailor-made, self-sufficient and recyclable monooxygenase catalyst based on coimmobilized cytochrome P450 BM3 and glucose dehydrogenase. Biotechnol Bioeng 2018; 115:2416-2425. [PMID: 30036448 PMCID: PMC6836874 DOI: 10.1002/bit.26802] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2018] [Revised: 07/12/2018] [Accepted: 07/16/2018] [Indexed: 12/18/2022]
Abstract
Cytochrome P450 monooxygenases (P450s) promote hydroxylations in a broad variety of substrates. Their prowess in C-H bond functionalization renders P450s promising catalysts for organic synthesis. However, operating P450 reactions involve complex management of the main substrates, O2 and nicotinamide adenine dinucleotide phosphate (NAD(P)H) reducing equivalents against an overall background of low operational stability. Whole-cell biocatalysis, although often used, offers no general solution to these problems. Herein, we present the design of a tailor-made, self-sufficient, operationally stabilized and recyclable P450 catalyst on porous solid support. Using enzymes as fusion proteins with the polycationic binding module Zbasic2 , the P450s BM3 (from Bacillus megaterium) was coimmobilized with glucose dehydrogenase (type IV; from B. megaterium) on anionic sulfopropyl-activated carrier (ReliSorb SP). Immobilization via Zbasic2 enabled each enzyme to be loaded in controllable amount, thus maximizing the relative portion of the rate limiting P450 BM3 (up to 19.5 U/gcarrier ) in total enzyme immobilized. Using lauric acid as a representative P450 substrate that is poorly accessible to whole-cell catalysts, we demonstrate complete hydroxylation at low catalyst loading (≤0.1 mol%) and efficient electron coupling (74%), inside of the catalyst particle, to the regeneration of NADPH from glucose (27 cycles) was achieved. The immobilized P450 BM3 showed a total turnover number of ∼18,000, thus allowing active catalyst to be recycled up to 20 times. This study therefore supports the idea of practical heterogeneous catalysis by P450s systems immobilized on solid support.
Collapse
Affiliation(s)
- Donya Valikhani
- Institute of Biotechnology and Biochemical Engineering, Graz University of Technology, Graz, Austria
| | - Juan M Bolivar
- Institute of Biotechnology and Biochemical Engineering, Graz University of Technology, Graz, Austria
| | - Alexander Dennig
- Institute of Biotechnology and Biochemical Engineering, Graz University of Technology, Graz, Austria.,Austrian Centre of Industrial Biotechnology, Graz, Austria
| | - Bernd Nidetzky
- Institute of Biotechnology and Biochemical Engineering, Graz University of Technology, Graz, Austria.,Austrian Centre of Industrial Biotechnology, Graz, Austria
| |
Collapse
|
41
|
Dong J, Fernández‐Fueyo E, Hollmann F, Paul CE, Pesic M, Schmidt S, Wang Y, Younes S, Zhang W. Biocatalytic Oxidation Reactions: A Chemist's Perspective. Angew Chem Int Ed Engl 2018; 57:9238-9261. [PMID: 29573076 PMCID: PMC6099261 DOI: 10.1002/anie.201800343] [Citation(s) in RCA: 271] [Impact Index Per Article: 45.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2018] [Indexed: 01/25/2023]
Abstract
Oxidation chemistry using enzymes is approaching maturity and practical applicability in organic synthesis. Oxidoreductases (enzymes catalysing redox reactions) enable chemists to perform highly selective and efficient transformations ranging from simple alcohol oxidations to stereoselective halogenations of non-activated C-H bonds. For many of these reactions, no "classical" chemical counterpart is known. Hence oxidoreductases open up shorter synthesis routes based on a more direct access to the target products. The generally very mild reaction conditions may also reduce the environmental impact of biocatalytic reactions compared to classical counterparts. In this Review, we critically summarise the most important recent developments in the field of biocatalytic oxidation chemistry and identify the most pressing bottlenecks as well as promising solutions.
Collapse
Affiliation(s)
- JiaJia Dong
- Department of BiotechnologyDelft University of Technologyvan der Maasweg 92629HZDelftThe Netherlands
| | - Elena Fernández‐Fueyo
- Department of BiotechnologyDelft University of Technologyvan der Maasweg 92629HZDelftThe Netherlands
| | - Frank Hollmann
- Department of BiotechnologyDelft University of Technologyvan der Maasweg 92629HZDelftThe Netherlands
| | - Caroline E. Paul
- Department of BiotechnologyDelft University of Technologyvan der Maasweg 92629HZDelftThe Netherlands
| | - Milja Pesic
- Department of BiotechnologyDelft University of Technologyvan der Maasweg 92629HZDelftThe Netherlands
| | - Sandy Schmidt
- Department of BiotechnologyDelft University of Technologyvan der Maasweg 92629HZDelftThe Netherlands
| | - Yonghua Wang
- School of Food Science and EngineeringSouth China University of TechnologyGuangzhou510640P. R. China
| | - Sabry Younes
- Department of BiotechnologyDelft University of Technologyvan der Maasweg 92629HZDelftThe Netherlands
| | - Wuyuan Zhang
- Department of BiotechnologyDelft University of Technologyvan der Maasweg 92629HZDelftThe Netherlands
| |
Collapse
|
42
|
Le‐Huu P, Rekow D, Krüger C, Bokel A, Heidt T, Schaubach S, Claasen B, Hölzel S, Frey W, Laschat S, Urlacher VB. Chemoenzymatic Route to Oxyfunctionalized Cembranoids Facilitated by Substrate and Protein Engineering. Chemistry 2018; 24:12010-12021. [DOI: 10.1002/chem.201802250] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2018] [Revised: 06/27/2018] [Indexed: 01/19/2023]
Affiliation(s)
- Priska Le‐Huu
- Institute of BiochemistryHeinrich-Heine University Düsseldorf Universitätsstrasse 1 40225 Düsseldorf Germany
| | - Dominik Rekow
- Institute of Organic ChemistryUniversity Stuttgart Pfaffenwaldring 55 70569 Stuttgart Germany
| | - Claudia Krüger
- Institute of Organic ChemistryUniversity Stuttgart Pfaffenwaldring 55 70569 Stuttgart Germany
| | - Ansgar Bokel
- Institute of BiochemistryHeinrich-Heine University Düsseldorf Universitätsstrasse 1 40225 Düsseldorf Germany
| | - Tanja Heidt
- Institute of Organic ChemistryUniversity Stuttgart Pfaffenwaldring 55 70569 Stuttgart Germany
| | - Sebastian Schaubach
- Institute of Organic ChemistryUniversity Stuttgart Pfaffenwaldring 55 70569 Stuttgart Germany
| | - Birgit Claasen
- Institute of Organic ChemistryUniversity Stuttgart Pfaffenwaldring 55 70569 Stuttgart Germany
| | - Sebastian Hölzel
- Institute of BiochemistryHeinrich-Heine University Düsseldorf Universitätsstrasse 1 40225 Düsseldorf Germany
| | - Wolfgang Frey
- Institute of Organic ChemistryUniversity Stuttgart Pfaffenwaldring 55 70569 Stuttgart Germany
| | - Sabine Laschat
- Institute of Organic ChemistryUniversity Stuttgart Pfaffenwaldring 55 70569 Stuttgart Germany
| | - Vlada B. Urlacher
- Institute of BiochemistryHeinrich-Heine University Düsseldorf Universitätsstrasse 1 40225 Düsseldorf Germany
| |
Collapse
|
43
|
Dong J, Fernández-Fueyo E, Hollmann F, Paul CE, Pesic M, Schmidt S, Wang Y, Younes S, Zhang W. Biokatalytische Oxidationsreaktionen - aus der Sicht eines Chemikers. Angew Chem Int Ed Engl 2018. [DOI: 10.1002/ange.201800343] [Citation(s) in RCA: 84] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Affiliation(s)
- JiaJia Dong
- Department of Biotechnology; Delft University of Technology; van der Maasweg 9 2629HZ Delft Niederlande
| | - Elena Fernández-Fueyo
- Department of Biotechnology; Delft University of Technology; van der Maasweg 9 2629HZ Delft Niederlande
| | - Frank Hollmann
- Department of Biotechnology; Delft University of Technology; van der Maasweg 9 2629HZ Delft Niederlande
| | - Caroline E. Paul
- Department of Biotechnology; Delft University of Technology; van der Maasweg 9 2629HZ Delft Niederlande
| | - Milja Pesic
- Department of Biotechnology; Delft University of Technology; van der Maasweg 9 2629HZ Delft Niederlande
| | - Sandy Schmidt
- Department of Biotechnology; Delft University of Technology; van der Maasweg 9 2629HZ Delft Niederlande
| | - Yonghua Wang
- School of Food Science and Engineering; South China University of Technology; Guangzhou 510640 P. R. China
| | - Sabry Younes
- Department of Biotechnology; Delft University of Technology; van der Maasweg 9 2629HZ Delft Niederlande
| | - Wuyuan Zhang
- Department of Biotechnology; Delft University of Technology; van der Maasweg 9 2629HZ Delft Niederlande
| |
Collapse
|
44
|
Tavanti M, Porter JL, Sabatini S, Turner NJ, Flitsch SL. Panel of New Thermostable CYP116B Self-Sufficient Cytochrome P450 Monooxygenases that Catalyze C−H Activation with a Diverse Substrate Scope. ChemCatChem 2018. [DOI: 10.1002/cctc.201701510] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Michele Tavanti
- School of Chemistry, Manchester Institute of Biotechnology; University of Manchester; 131 Princess Street Manchester M1 7DN UK
| | - Joanne L. Porter
- School of Chemistry, Manchester Institute of Biotechnology; University of Manchester; 131 Princess Street Manchester M1 7DN UK
| | - Selina Sabatini
- School of Chemistry, Manchester Institute of Biotechnology; University of Manchester; 131 Princess Street Manchester M1 7DN UK
| | - Nicholas J. Turner
- School of Chemistry, Manchester Institute of Biotechnology; University of Manchester; 131 Princess Street Manchester M1 7DN UK
| | - Sabine L. Flitsch
- School of Chemistry, Manchester Institute of Biotechnology; University of Manchester; 131 Princess Street Manchester M1 7DN UK
| |
Collapse
|
45
|
Stereoselective hydroxylation of isophorone by variants of the cytochromes P450 CYP102A1 and CYP101A1. Enzyme Microb Technol 2018; 111:29-37. [PMID: 29421034 DOI: 10.1016/j.enzmictec.2018.01.002] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2017] [Revised: 01/02/2018] [Accepted: 01/04/2018] [Indexed: 11/23/2022]
Abstract
The stereoselective oxidation of hydrocarbons is an area of research where enzyme biocatalysis can make a substantial impact. The cyclic ketone isophorone was stereoselectively hydroxylated (≥95%) by wild-type CYP102A1 to form (R)-4-hydroxyisophorone, an important chiral synthon and flavour and fragrance compound. CYP102A1 variants were also selective for 4-hydroxyisophorone formation and the product formation rate increased over the wild-type enzyme by up to 285-fold, with the best mutants being R47L/Y51F/I401P and A74G/F87V/L188Q. The latter variant, which contained mutations in the distal substrate binding pocket, was marginally less selective. Combining perfluorodecanoic acid decoy molecules with the rate accelerating variant R47L/Y51F/I401P engendered further improvement with the purified enzymes. However when the decoy molecules were used with A74G/F87V/L188Q the amount of product generated by the enzyme was reduced. Addition of decoy molecules to whole-cell turnovers did not improve the productivity of these CYP102A1 systems. WT CYP101A1 formed significant levels of 7-hydroxyisophorone as a minor product alongside 4-hydroxyisophorone. However the F87W/Y96F/L244A/V247L CYP101A1 mutant was ≥98% selective for (R)-4-hydroxyisophorone. A comparison of the two enzyme systems using whole-cell oxidation reactions showed that the best CYP101A1 variant was able to generate more product. We also characterised that the further oxidation metabolite 4-ketoisophorone was produced and then subsequently reduced to levodione by an endogenous Escherichia coli ene reductase.
Collapse
|
46
|
Tavanti M, Parmeggiani F, Castellanos JRG, Mattevi A, Turner NJ. One-Pot Biocatalytic Double Oxidation of α-Isophorone for the Synthesis of Ketoisophorone. ChemCatChem 2017. [DOI: 10.1002/cctc.201700620] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Affiliation(s)
- Michele Tavanti
- Manchester Institute of Biotechnology (MIB); School of Chemistry; The University of Manchester; 131 Princess Street M1 7DN Manchester United Kingdom
| | - Fabio Parmeggiani
- Manchester Institute of Biotechnology (MIB); School of Chemistry; The University of Manchester; 131 Princess Street M1 7DN Manchester United Kingdom
| | - J. Rubén Gómez Castellanos
- Department of Biology and Biotechnology “Lazzaro Spallanzani”; University of Pavia; Via Ferrata 9 27100 Pavia Italy
| | - Andrea Mattevi
- Department of Biology and Biotechnology “Lazzaro Spallanzani”; University of Pavia; Via Ferrata 9 27100 Pavia Italy
| | - Nicholas J. Turner
- Manchester Institute of Biotechnology (MIB); School of Chemistry; The University of Manchester; 131 Princess Street M1 7DN Manchester United Kingdom
| |
Collapse
|
47
|
Klenk JM, Nebel BA, Porter JL, Kulig JK, Hussain SA, Richter SM, Tavanti M, Turner NJ, Hayes MA, Hauer B, Flitsch SL. The self-sufficient P450 RhF expressed in a whole cell system selectively catalyses the 5-hydroxylation of diclofenac. Biotechnol J 2017; 12. [DOI: 10.1002/biot.201600520] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2016] [Revised: 01/12/2016] [Accepted: 01/18/2017] [Indexed: 12/22/2022]
Affiliation(s)
- Jan M. Klenk
- Institute of Technical Biochemistry; University of Stuttgart; Stuttgart Germany
| | - Bernd A. Nebel
- Institute of Technical Biochemistry; University of Stuttgart; Stuttgart Germany
| | - Joanne L. Porter
- School of Chemistry; Manchester Institute of Biotechnology; The University of Manchester; Manchester UK
| | - Justyna K. Kulig
- Cardiovascular and Metabolic Diseases DMPK; Innovative Medicines and Early Development Biotech Unit; AstraZeneca; Mölndal Sweden
- Present address: Crop Science Division; Bayer AG; Monheim am Rhein Germany
| | - Shaneela A. Hussain
- School of Chemistry; Manchester Institute of Biotechnology; The University of Manchester; Manchester UK
| | - Sven M. Richter
- Institute of Technical Biochemistry; University of Stuttgart; Stuttgart Germany
| | - Michele Tavanti
- School of Chemistry; Manchester Institute of Biotechnology; The University of Manchester; Manchester UK
| | - Nicholas J. Turner
- School of Chemistry; Manchester Institute of Biotechnology; The University of Manchester; Manchester UK
| | - Martin A. Hayes
- Cardiovascular and Metabolic Diseases DMPK; Innovative Medicines and Early Development Biotech Unit; AstraZeneca; Mölndal Sweden
| | - Bernhard Hauer
- Institute of Technical Biochemistry; University of Stuttgart; Stuttgart Germany
| | - Sabine L. Flitsch
- School of Chemistry; Manchester Institute of Biotechnology; The University of Manchester; Manchester UK
| |
Collapse
|
48
|
O'Hanlon JA, Ren X, Morris M, Wong LL, Robertson J. Hydroxylation of anilides by engineered cytochrome P450BM3. Org Biomol Chem 2017; 15:8780-8787. [DOI: 10.1039/c7ob02236k] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Cytochrome P450BM3mutants achieve selectivepara-hydroxylation of substitutedN-sulfonylanilines under mild conditions.
Collapse
Affiliation(s)
- Jack A. O'Hanlon
- Department of Chemistry
- University of Oxford
- Chemistry Research laboratory
- Oxford
- UK
| | - Xinkun Ren
- Department of Chemistry
- University of Oxford
- Inorganic Chemistry Laboratory
- Oxford
- UK
| | - Melloney Morris
- Syngenta UK
- Jealott's Hill International Research Centre
- Bracknell
- UK
| | - Luet Lok Wong
- Department of Chemistry
- University of Oxford
- Inorganic Chemistry Laboratory
- Oxford
- UK
| | - Jeremy Robertson
- Department of Chemistry
- University of Oxford
- Chemistry Research laboratory
- Oxford
- UK
| |
Collapse
|